Skip to main content

Smith, Salley & Associates

SEC CIK
0001482012
Latest filing
Jul 23, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Smith, Salley & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2024
Holdings of SRPT by Smith, Salley & Associates, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−7,308−100.0%Sold outHolders
Q1 20257,308$466.4K<0.1%00.0%UnchangedHolders
Q4 20247,308$888.6K0.1%+7,308NewHolders